Axsome Therapeutics Inc said on Friday the U.S. Food and Drug Administration approved its oral drug for the treatment of depression in adults, sending its shares up 17% in premarket trading. The company faced a delay in getting the agency’s approval for the drug last year…

Read Full Article (External Site)